Post-market clinical follow-up under the EU MDR

Congenius

Congenius

Topical Articles

Post-market clinical follow-up (PMCF) has become significantly more rigorous under the EU MDR to ensure enhanced patient safety following a device’s entry onto the market.

In the 5-minute guide below, our Clinical Consultant Dr. Martina Hersberger and Head of Clinical Dr. Sarah Bosshard share an overview of PMCF and its requirements, along with important advice on the essential do’s and don’ts.

Do you have a PMCF challenge? Our Clinical team is ready and happy to help – simply get in touch to start the conversation.

Related News & Knowledge

×

Request a demo

Find out more about QMgeniuS by requesting a demo.

Simply fill out your details and click “Request a demo", then a member of the team will get back to you shortly.

Alternatively, feel free to give us a call on +41 44 741 04 04 to start the conversation. We look forward to hearing from you!